Gualtieri P, Frank G, Cianci R, Ciancarella L, Romano L, Ortoman M
Nutrients. 2025; 17(5).
PMID: 40077790
PMC: 11901643.
DOI: 10.3390/nu17050922.
Uthaman S, Kang W, Park J, Kim S, Le D, Oh S
Heliyon. 2025; 11(4):e42673.
PMID: 40034321
PMC: 11875816.
DOI: 10.1016/j.heliyon.2025.e42673.
Zhao L, Li J, Dang Y, Fisher D, Hien N, Musabaev E
Mol Biol Rep. 2025; 52(1):241.
PMID: 39961997
DOI: 10.1007/s11033-025-10358-w.
Beaver L, Jamieson P, Wong C, Hosseinikia M, Stevens J, Ho E
Adv Nutr. 2025; 16(3):100376.
PMID: 39832641
PMC: 11847308.
DOI: 10.1016/j.advnut.2025.100376.
Xu Z, Liu D, Zhu J, Zhao J, Shen S, Wang Y
Planta. 2024; 261(1):16.
PMID: 39690279
DOI: 10.1007/s00425-024-04594-w.
Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer's Disease Model: A Network-Transcriptomic Analysis.
Minuti A, Mazzon E, Iori R, Chiricosta L, Artimagnella O
Nutrients. 2024; 16(23).
PMID: 39683594
PMC: 11644231.
DOI: 10.3390/nu16234202.
Sulforaphane attenuates phosgene-induced acute lung injury via the Nrf2-HO-1/NQO1 pathway.
Lu Q, Huang S, Zhao Y, Yu S, Shi M, Li J
J Thorac Dis. 2024; 16(10):6604-6615.
PMID: 39552873
PMC: 11565325.
DOI: 10.21037/jtd-24-819.
Molecular mechanisms of sulforaphane in Alzheimer's disease: insights from an in-silico study.
Vu G, Nguyen H
In Silico Pharmacol. 2024; 12(2):96.
PMID: 39493676
PMC: 11530583.
DOI: 10.1007/s40203-024-00267-4.
The role of isothiocyanate-rich plants and supplements in neuropsychiatric disorders: a review and update.
Ramakrishnan M, Fahey J, Zimmerman A, Zhou X, Panjwani A
Front Nutr. 2024; 11:1448130.
PMID: 39421616
PMC: 11484503.
DOI: 10.3389/fnut.2024.1448130.
Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy.
Zheng Y, Chen X, Wang Y, Chen Z, Wu D
J Zhejiang Univ Sci B. 2024; 25(10):890-913.
PMID: 39420524
PMC: 11494163.
DOI: 10.1631/jzus.B2300839.
The Nrf2-HO-1 system and inflammaging.
ORourke S, Shanley L, Dunne A
Front Immunol. 2024; 15:1457010.
PMID: 39380993
PMC: 11458407.
DOI: 10.3389/fimmu.2024.1457010.
Effect of Illite Treatment on Quality Characteristics and Antioxidant Activity of Broccoli ( L. var. ) Sprouts.
Kim S, Dhungana S, Kim I, Adhikari A, Kim J
Molecules. 2024; 29(18).
PMID: 39339342
PMC: 11434328.
DOI: 10.3390/molecules29184347.
Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents.
Patel B, Greenland J, Williams-Gray C
J Parkinsons Dis. 2024; 14(7):1283-1300.
PMID: 39331111
PMC: 11492043.
DOI: 10.3233/JPD-240353.
Sulforaphane and ophthalmic diseases.
Zhang Y, Zhao X, Liu Y, Yang X
Food Sci Nutr. 2024; 12(8):5296-5311.
PMID: 39139965
PMC: 11317731.
DOI: 10.1002/fsn3.4230.
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications.
Mayer C, Riera-Ponsati L, Kauppinen S, Klitgaard H, Erler J, Hansen S
Front Pharmacol. 2024; 15:1437939.
PMID: 39119604
PMC: 11306042.
DOI: 10.3389/fphar.2024.1437939.
Sulforaphane Effects on Neuronal-like Cells and Peripheral Blood Mononuclear Cells Exposed to 2.45 GHz Electromagnetic Radiation.
Bertuccio M, Saija C, Acri G, Ientile R, Caccamo D, Curro M
Int J Mol Sci. 2024; 25(14).
PMID: 39063113
PMC: 11276899.
DOI: 10.3390/ijms25147872.
Sulforaphane Inhibits Oxidative Stress and May Exert Anti-Pyroptotic Effects by Modulating NRF2/NLRP3 Signaling Pathway in -Infected Macrophages.
Chen G, Shen L, Hu H, Feng Y, Wen D, Liu Y
Microorganisms. 2024; 12(6).
PMID: 38930573
PMC: 11205970.
DOI: 10.3390/microorganisms12061191.
Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products.
Yang K, Zeng L, He Q, Wang S, Xu H, Ge J
Front Pharmacol. 2024; 15:1250918.
PMID: 38601463
PMC: 11004298.
DOI: 10.3389/fphar.2024.1250918.
Emerging Roles of Extracelluar Vesicles Derived from Bacteria, Mammalian or Plant Cells in the Pathogenesis and Clinical Application of Neurodegenerative Diseases.
Li Y, Zhou C, Liu H, Cai T, Fan H
Biomolecules. 2024; 14(3).
PMID: 38540732
PMC: 10968246.
DOI: 10.3390/biom14030312.
Mitochondria-Targeted Antioxidant Therapeutics for Traumatic Brain Injury.
Modi H, Musyaju S, Ratcliffe M, Shear D, Scultetus A, Pandya J
Antioxidants (Basel). 2024; 13(3).
PMID: 38539837
PMC: 10967339.
DOI: 10.3390/antiox13030303.